glp 1 drugs and thyroid cancer GLP-1 Receptor Agonists: A Promising Therapy for Modern Lifestyle Diseases with Unforeseen Challenges Thyroid cancer survivor wondering about

Whether you are on semaglutide , tirzepatide , or exploring retatrutide , SeekPeptides built this resource so you would never have to guess what comes next

Wegovy is the first once-weekly GLP-1 receptor agonist approved as a weight loss medication for people under the age of 18

Codeage GLP-1 Probiotic+ supplement offers a potent 500 million AFUs* of live probiotics, including Akkermansia muciniphila, Clostridium butyricum, Bifidobacterium infantis, and chicory inulin

Why does this matter

It is well established that patients with diabetes demonstrate higher susceptibility to pancreatic cancer and pancreatitis compared to non-diabetic individuals, and theoretically, sustained GLP-1 receptor activation induced by GLP-1RA therapy may potentially elevate pancreatic cancer risk [8]

found that the use of exenatide once weekly has nonsignificant effects on LDL-C levels with a change of -0.05 mmol/L 0.05 mmol/L, suggesting that the effect of GLP-1 RAs on LDL-C levels requires further research [67]